Market Currents
Regeneron (REGN +2.5%) finishes the day higher, after its price target was raised to $175 from...
-
Thursday, October 4, 2012, 3:59 PM ETRegeneron (REGN +2.5%) finishes the day higher, after its price target was raised to $175 from $150 at RW Baird earlier today. The firm cites an upbeat survey for Eylea, and raises its estimates ahead of its Q3 results.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
